Rob Paulsen on Facing Cancer and the Pandemic with a Smile

Video

Dealing with cancer can be a stressful enough experience without having to navigate a worldwide pandemic, as many are doing due to COVID-19. But according to Rob Paulsen, voice actor and throat cancer survivor, the key to making it through each day may be in finding a reason to smile.

For Oral Head and Neck Cancer Awareness Week, we spoke with Paulsen about what it was like to be diagnosed with stage 3 metastatic squamous cell carcinoma when he had been making a living with his voice for nearly three decades. “What’s the axiom we’ve heard a zillion times?” he asked in the interview. “‘We make plans and God laughs?’”

Best known for his roles on animated series like “Animaniacs” and “Pinky and the Brain,” Paulsen is now taking on his role as the 2020 Head and Neck Cancer Alliance celebrity spokesperson with the same enthusiasm he has for finding the joy in each day. Here, he goes into detail about how he’s raising awareness about the disease while weathering the COVID-19 pandemic.

“There are going to be something like 600,000 cases of HPV-related head and neck cancer diagnosed this year worldwide,” Paulsen explains, adding that the information and resources found through the Head and Neck Cancer Alliance offer hope to patients, survivors and caregivers alike.

Through it all, Paulsen says the best advice he can give is to find a way to smile, whether it’s in dealing with cancer or COVID-19. “It sounds so simple: I say laughter is the best medicine, but the cool thing is you can’t overdose, and refills are free,” Paulsen said. “I’m not stupid enough to think you can laugh your way out of brain cancer or throat cancer or breast cancer, but I’ve met many folks who have gone through far worse than I and come out the other end not only with a renewed sense of priorities but a real keen sense of humor.”

“I have had the gift of cancer, and when I’ve gotten to be able to see how people behave, even when they know they’re on their way out sometimes, it’s nothing sort of astonishing, the power of the human spirit. And it’s always, unfailingly, attached to humor or joy in some way. I encourage people to find any joy they can.”

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE
Related Content